Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)-Reference-Cited by-同舟云学术

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

Published:2009-12-10 Issue:5 Volume:89 Page:489-497
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Eom Hyeon-Seok,Kim Yeo-Kyeoung,Chung Joo-Seop,Kim Kihyun,Kim Hyo Jung,Kim Ho Young,Jin Jong-Youl,Do Young-Rok,Oh Suk-Joong,Suh Cheolwon,Seong Chu-Myong,Kim Chul Soo,Lee Dong Soon,Lee Jae Hoon

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-009-0871-y.pdf

Reference31 articles.

1. Attal M, Harousseau JL, Stoppa AM et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 335:91–97

2. Child JA, Morgan GJ, Davies FE et al (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348:1875–1883

3. Edwards BK, Brown ML, Wingo PA et al (2005) Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407–1427

4. Barlogie B, Anaissie E, van Rhee F et al (2007) Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3. Br J Haematol 138:176–185

5. Pineda-Roman M, Zangari M, van Rhee F et al (2008) VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma. Leukemia 22:1419–1427

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma;Blood Reviews;2023-09

2. Safety and comfort of domestic bortezomib injection in real-life experience;Supportive Care in Cancer;2018-03-24

3. Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma;British Journal of Haematology;2017-06-07

4. Recent advances in multiple myeloma: a Korean perspective;The Korean Journal of Internal Medicine;2016-09-01

5. Cancer-associated Kidney Disease;The Korean Journal of Medicine;2016-05-01